Terms: = Leukemia AND HEY1, CHF-2, 23462, ENSG00000164683, HESR1, CHF2, HESR-1, MGC1274, HRT-1, OAF1, HERP2 AND Treatment
3 results:
1. TM5614, an Inhibitor of Plasminogen Activator Inhibitor-1, Exerts an Antitumor Effect on Chronic Myeloid leukemia.
Sasaki K; Fujiwara T; Ochi T; Ono K; Kato H; Onodera K; Ichikawa S; Fukuhara N; Onishi Y; Yokoyama H; Miyata T; Harigae H
Tohoku J Exp Med; 2022 Jun; 257(3):211-224. PubMed ID: 35491124
[TBL] [Abstract] [Full Text] [Related]
2. Changes in gene expression profile in two multidrug resistant cell lines derived from a same drug sensitive cell line.
Moreira MA; Bagni C; de Pinho MB; Mac-Cormick TM; dos Santos Mota M; Pinto-Silva FE; Daflon-Yunes N; Rumjanek VM
Leuk Res; 2014 Aug; 38(8):983-7. PubMed ID: 24996974
[TBL] [Abstract] [Full Text] [Related]
3. NK-like homeodomain proteins activate NOTCH3-signaling in leukemic T-cells.
Nagel S; Venturini L; Przybylski GK; Grabarczyk P; Meyer C; Kaufmann M; Battmer K; Schmidt CA; Drexler HG; Scherr M; Macleod RA
BMC Cancer; 2009 Oct; 9():371. PubMed ID: 19835636
[TBL] [Abstract] [Full Text] [Related]
